API Development Sample Clauses

API Development. Aratana will use commercially reasonable efforts to develop and establish a manufacturing process for the API that is cGMP compliant and fully characterized and substantially conforms to the Specifications. The target date for completion is no later than [***], provided that Aratana could be delayed due to causes beyond Aratana’s reasonable control. In case that Aratana finds the causes of delay, Aratana should promptly notify RaQualia the causes and the Parties will negotiate and set the next target date. Aratana anticipates all development of the API will take place at Cambridge Major Laboratories (“CML”) and will be performed as generally described in [***] attached hereto as Exhibit B.
Sample 1Sample 2
AutoNDA by SimpleDocs
API Development. An API is a software intermediary that allows two applications to talk to each other. In the context of the Company's Flexibility Services, the API replaces the requirement for dedicated hardware to be provided to connect to a Provider’s sites in order to collect the metering data and send control requests from the central control desk. Providers are expected to develop their own interface for the API to the assets that they intend to offer to the Company. Due to the large variety of potential scenarios that can occur, ranging from a single asset such as a standalone generator through to a complex estate with multiple assets or even part of a portfolio under management by a commercial aggregator. The objective of the Provider is to establish a single point where they can aggregate the metering from all assets within a DER set along with communications to send to the Company, and are able to receive start and stop requests. It is at this point that we would expect a device such as a server to be hosting an API software program. A comprehensive guide to API set-up is available on xxx.xxxxxxxxxxxxx.xx.xx/xxxxxxxxx/000.
Sample 1Sample 2
API Development. After the Effective Date identified below, Entrata will provide specifications for the APIs outlined on Exhibit A. Entrata and Developer agree to work together in good faith as reasonably necessary to facilitate the completion of the APIs for their Common Clients’ benefit. Both parties will maintain and support the APIs. The parties agree that the APIs may be updated or revised to include improvements, upgrades, or other changes as required by Entrata. The parties agree to provide each other with technical assistance as the APIs may reasonably require. All costs for software modifications to Developer’s Application shall be the exclusive obligation of Developer.
Sample 1Sample 2
API Development. Replay will use its best efforts to develop and document mutually agreed upon Replay Device Software APIs reasonably necessary for the development of MKE Products that combine Replay Technology with other features and functionality developed or provided by MKE. In the event that MKE experiences significant difficulty in utilizing such APIs in connection with the development of such products, Replay will, at MKE's request, consider in good faith providing source code updates and modifications for the applicable portions of [***]= CERTAIN INFORMATION ON THIS PAGE HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. the Replay Device Software on a case-by-case basis. Any provision by Replay of such Replay Device Software source code updates and modifications shall be subject to the provisions of Section 3 hereof.
Sample 1Sample 2
API Development. 4.6.1. An API is a software intermediary that allows two applications to talk to each other. In the context of the Company's Flexibility Services, the API replaces the requirement for dedicated hardware to be provided to connect to a Provider’s sites in order to collect metering data and send control messages.
Sample 1
API Development. Subject to the terms of this Agreement, SB --------------- developed and provided: (i) a suite of APIs to query, the [**] Database (collectively, "SB APIs") and a series of tools to insert, edit and update the [**] Database, in each case as further described in Exhibit C, and (ii) other methods of data access as set forth in Exhibit C. To the extent reasonably requested by AOL, SB shall develop appropriate APIs and tools for use with the [**]D atabase in accordance with the terms of this Agreement.
Sample 1
API Development. Subject to the terms of this Agreement, AOL --------------- has developed and provided a suite of APIs to query, insert, edit and update the [**]Database to access AOL Features or Functionality and to interoperate with the AOL YP User Interface.
Sample 1
AutoNDA by SimpleDocs
API Development. Organichem shall develop the API in a timely manner and in accordance with FDA requirements, applicable requirements of the U.S. Pharmacopeia (USP), and such other specifications as shall be mutually agreed upon in writing by Organichem and Purepac.
Sample 1
API Development. Friendable will develop a set of network service API’s to communicate with the applications (IOS, Android, and Web) as well as CTI. API’s will be a central location for all platforms to communicate and to ensure that everything is always in sync. These include: - Architect and Design of Database table structure - Creation of approx. 30 – 40 new endpoints required (as per the API spec doc) - Device and notification management – SNS subscribe / Unsubscribe - Creation of routines to communicate changes to CTI - Create a full set of Developer Documentation - Create automated routines for task reminders, schedule changes, etc. - Bot creation or Lambda function for Log management and reporting, server cleanup, stats, admin feeds, timed events, turning off account access for past due payments, etc.
Sample 1

Related to API Development

  • Clinical Development Licensee will have sole responsibility for and sole decision making over the clinical development of any Product arising from the Research Program in the Field. Notwithstanding the foregoing, if Licensee wishes to conduct clinical development of a Development Candidate at Penn and Penn has the clinical expertise, interest and ability to run such a trial as assessed at Penn’s sole discretion, such a study will be conducted under a separate Clinical Trial Agreement to be negotiated by the Parties prior to initiation of such study. Such separate clinical trial agreement will include a detailed clinical development plan, including costs and time lines for conducting the Clinical Trial.

  • Research and Development (i) Advice and assistance in relation to research and development of Party B;

  • Joint Development If joint development is involved, the Recipient agrees to follow the latest edition of FTA Circular 7050.1, “Federal Transit Administration Guidance on Joint Development.”

  • Initial Development Plan Not later than the Effective Date, Licensee shall have provided Merck with an initial Development plan for the Licensed Product in the Field in the Territory, which shall be incorporated as part of this Agreement as Attachment 3.02(a) (as may be amended in accordance with this Agreement, the “Development Plan”). **CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

  • Development 3.3 Within twenty (20) Working Days after the Commencement Date and in accordance with paragraphs 3.10 to 3.12 (Amendment and Revision), the Contractor will prepare and deliver to the Authority for approval the full and final Security Plan which will be based on the draft Security Plan set out in Appendix B.

  • Business Development Provide advice and assistance in business growth and development of Party B. 业务发展。对乙方的业务发展提供建议和协助。

  • Product Development Attach all requested documentation and attach additional pages as necessary. For all requirements include efforts of all Sublicensees. If not applicable, please so indicate by N/A.

  • Independent Development Receiving Party may currently or in the future be developing information internally, or receiving information internally, or receiving information from other parties that may be similar to the Disclosing Party's Confidential Information. Accordingly, nothing in this Agreement will be construed as a representation or inference that Receiving Party will not develop or have developed products or services, that, without violation of this Agreement, might compete with the products or systems contemplated by the Disclosing Party's Confidential Information.

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time.

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!